Pharmabiz6h
Annovis Bio gets US FDA clearance to begin pivotal phase 3 studies of buntanetap, paving the way for NDAs filing
Annovis Bio gets US FDA clearance to begin pivotal phase 3 studies of buntanetap, paving the way for NDAs filing: Malvern, Pennsylvania Thursday, October 17, 2024, 18:00 Hrs [IST] ...
Pharmabiz7h
SkinBB launches Skincare Metaverse, merging AI technology with dermatological expertise for consumer empowerment
SkinBB launches Skincare Metaverse, merging AI technology with dermatological expertise for consumer empowerment: Our Bureau, Mumbai Thursday, October 17, 2024, 17:15 Hrs [IST] In ...
Pharmabiz7h
Monopar expands radiopharma IP portfolio with patent filing on new compounds and linkers
Monopar expands radiopharma IP portfolio with patent filing on new compounds and linkers: Wilmette, Illinois Thursday, October 17, 2024, 17:30 Hrs [IST] Monopar Therapeutics Inc., ...
Pharmabiz15h
Merck’s STRIDE-8 phase 3 trial of Capvaxive demonstrates positive immune responses in adults with increased risk for pneumococcal disease
Merck’s STRIDE-8 phase 3 trial of Capvaxive demonstrates positive immune responses in adults with increased risk for pneumococcal disease: Rahway, New Jersey Thursday, October 1 ...
Pharmabiz11h
L V Prasad Eye Institute founder highlights creation of infrastructure for corneal transplants in India
L V Prasad Eye Institute founder highlights creation of infrastructure for corneal transplants in India: Our Bureau, Bengaluru Thursday, October 17, 2024, 13:30 Hrs [IST] Dr Gulla ...
Pharmabiz8h
Cullinan Therapeutics gets US FDA clearance to proceed phase 1 trial of CLN-978 in patients with moderate to severe systemic lupus erythematosus
Cambridge, Massachusetts Thursday, October 17, 2024, 17:00 Hrs [IST] ...
Pharmabiz9h
Immuneering Corporation’s drug candidate IMM-1-104 receives US FDA orphan drug designation for treatment of pancreatic cancer
Immuneering Corporation’s drug candidate IMM-1-104 receives US FDA orphan drug designation for treatment of pancreatic cancer: Cambridge, Massachusetts Thursday, October 17, 202 ...
Pharmabiz8h
Eight Roads Ventures, McKinsey note global CRDMO work distribution in India to rise up to 10% by 2033
Our Bureau, Bengaluru Thursday, October 17, 2024, 16:15 Hrs [IST] ...
Pharmabiz10h
Johnson & Johnson announces positive results from phase 2/3 Vibrance-MG study of nipocalimab in adolescents living with generalized myasthenia gravis
Johnson & Johnson announces positive results from phase 2/3 Vibrance-MG study of nipocalimab in adolescents living with generalized myasthenia gravis: Savannah, Georgia Thursday, ...
Pharmabiz8h
Bayer introduces Bepanthen in India as new survey reveals dry skin affects 1 in 2 Indians
Our Bureau, Mumbai Thursday, October 17, 2024, 16:30 Hrs [IST] ...
Pharmabiz9h
Gennet Lab and Estonian Embassy inks pact with Sterlite Technologies for healthcare solutions
Gennet Lab and Estonian Embassy inks pact with Sterlite Technologies for healthcare solutions: Our Bureau, Bengaluru Thursday, October 17, 2024, 15:40 Hrs [IST] Gennet Lab, one of ...
Pharmabiz13h
NIH & US FDA leaders call for innovation in development of smoking cessation treatments
NIH & US FDA leaders call for innovation in development of smoking cessation treatments: Bethesda, Maryland Thursday, October 17, 2024, 12:00 Hrs [IST] In a new commentary in the ...